Ahead of the COREPER (Committee of the Permanent Representatives of the Governments of the Member States to the European Union, Council of the EU) meeting on February 2, the AI Act is facing some internal opposition, creating uncertainty over the Council’s timelines for adoption.
Member states have been raising concerns over the EU AI Act’s impact on innovation
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?